Adma Biologics Stock Cycle Indicators Hilbert Transform Dominant Cycle Period

ADMA Stock  USD 21.18  0.12  0.56%   
ADMA Biologics cycle indicators tool provides the execution environment for running the Hilbert Transform Dominant Cycle Period indicator and other technical functions against ADMA Biologics. ADMA Biologics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of cycle indicators indicators. As with most other technical indicators, the Hilbert Transform Dominant Cycle Period indicator function is designed to identify and follow existing trends. Cycle Indicators are used by chartists in order to analyze variations of the instantaneous phase or amplitude of ADMA Biologics price series.

Indicator
The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The Hilbert Transform - Dominant Cycle Period indicator is used to generate in-phase and quadrature components of ADMA Biologics price series in order to analyze variations of the instantaneous cycles.

ADMA Biologics Technical Analysis Modules

Most technical analysis of ADMA Biologics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ADMA from various momentum indicators to cycle indicators. When you analyze ADMA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About ADMA Biologics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ADMA Biologics. We use our internally-developed statistical techniques to arrive at the intrinsic value of ADMA Biologics based on widely used predictive technical indicators. In general, we focus on analyzing ADMA Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ADMA Biologics's daily price indicators and compare them against related drivers, such as cycle indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of ADMA Biologics's intrinsic value. In addition to deriving basic predictive indicators for ADMA Biologics, we also check how macroeconomic factors affect ADMA Biologics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Dividend Yield0.07810.0694
Price To Sales Ratio3.923.72
Hype
Prediction
LowEstimatedHigh
16.2520.9625.67
Details
Intrinsic
Valuation
LowRealHigh
6.7311.4423.30
Details
Naive
Forecast
LowNextHigh
13.5418.2422.95
Details
5 Analysts
Consensus
LowTargetHigh
5.466.006.66
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ADMA Biologics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ADMA Biologics' short interest history, or implied volatility extrapolated from ADMA Biologics options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Entertainment Idea
Entertainment
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
FinTech Idea
FinTech
Invested over 60 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 30 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Chemicals Idea
Chemicals
Invested over 30 shares
Momentum Idea
Momentum
Invested over 60 shares
When determining whether ADMA Biologics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ADMA Biologics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Adma Biologics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Adma Biologics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ADMA Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADMA Biologics. If investors know ADMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADMA Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
14
Earnings Share
0.27
Revenue Per Share
1.661
Quarterly Revenue Growth
0.781
Return On Assets
0.1989
The market value of ADMA Biologics is measured differently than its book value, which is the value of ADMA that is recorded on the company's balance sheet. Investors also form their own opinion of ADMA Biologics' value that differs from its market value or its book value, called intrinsic value, which is ADMA Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADMA Biologics' market value can be influenced by many factors that don't directly affect ADMA Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ADMA Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ADMA Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADMA Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.